Our mission is to create more effective precision medicines for patients with chronic diseases and cancers faster and at lower cost using our core technologies.
Executive Summary & Latest Updates
Industry Partners & Collaborators
Afecta has a long history of successful collaboration in drug discovery and development and looks to expand our industry partnerships.
Supernus Pharmaceuticals Inc.
(NASDAQ: SUPN)
Allergan PLC
(NYSE: ABBV)
LEO Pharma A/S
Our current development programs seek to transform treatment paradigms for neurologic, ophthalmologic, dermatologic, and malignant disorders.
Afecta has early clinical stage lead drugs, state-of-the-art A.I. computational platforms, proprietary databases, computer-assisted modeling/design tools, and novel drug delivery technologies.
